Market Tracker

06/23 5:16pm ET

Omeros Corp (NASDAQ:OMER)

25.71
Delayed Data
As of Jun 23
 -0.85 / -3.20%
Today’s Change
7.20
Today|||52-Week Range
27.09
+159.17%
Year-to-Date
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Omeros (OMER) Lead Candidate Gets Breakthrough Designation
Jun 14 / Zacks.com - Paid Partner Content
Omeros (OMER) Hits New 52-Week High on Positive FDA Decision
Jun 16 / Zacks.com - Paid Partner Content
Omeros (OMER) Worth a Look: Stock Adds 11.8% in Session
Jun 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close26.56
Today’s open26.34
Day’s range24.99 - 26.60
Volume2,388,267
Average volume (3 months)792,634
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+20.26%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.36+2.05%
TXMDTherapeuticsMD Inc-0.02-0.35%
SGYPSynergy Pharmaceutic...+0.15+3.27%
IPXLImpax Laboratories I...+0.20+1.21%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts